IN2014DN02241A - - Google Patents

Download PDF

Info

Publication number
IN2014DN02241A
IN2014DN02241A IN2241DEN2014A IN2014DN02241A IN 2014DN02241 A IN2014DN02241 A IN 2014DN02241A IN 2241DEN2014 A IN2241DEN2014 A IN 2241DEN2014A IN 2014DN02241 A IN2014DN02241 A IN 2014DN02241A
Authority
IN
India
Prior art keywords
relates
present
drug
internal standard
quantitative analysis
Prior art date
Application number
Other languages
English (en)
Inventor
Steven Lewis Ramsay
Wolfgang Guggenbichler
Klaus Michael Weinberger
Armin Graber
Wolfgang Markus STÖGGL
Original Assignee
Biocrates Life Sciences Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrates Life Sciences Ag filed Critical Biocrates Life Sciences Ag
Publication of IN2014DN02241A publication Critical patent/IN2014DN02241A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00594—Quality control, including calibration or testing of components of the analyser
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Evolutionary Biology (AREA)
  • Databases & Information Systems (AREA)
  • Medical Informatics (AREA)
  • Bioethics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Quality & Reliability (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
IN2241DEN2014 2005-06-30 2006-06-29 IN2014DN02241A (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69498305P 2005-06-30 2005-06-30
US69498405P 2005-06-30 2005-06-30
PCT/EP2006/006328 WO2007003344A2 (en) 2005-06-30 2006-06-29 Device for quantitative analysis of a metabolite profile

Publications (1)

Publication Number Publication Date
IN2014DN02241A true IN2014DN02241A (uk) 2015-07-10

Family

ID=36783737

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2241DEN2014 IN2014DN02241A (uk) 2005-06-30 2006-06-29

Country Status (16)

Country Link
US (2) US8265877B2 (uk)
EP (2) EP1875401B1 (uk)
JP (2) JP4829297B2 (uk)
KR (1) KR100967573B1 (uk)
CN (1) CN100594501C (uk)
AU (1) AU2006265381B2 (uk)
BR (1) BRPI0613478B8 (uk)
CA (2) CA2608965C (uk)
DK (2) DK1875401T3 (uk)
ES (1) ES2452025T3 (uk)
IL (1) IL187470A (uk)
IN (1) IN2014DN02241A (uk)
NO (1) NO339319B1 (uk)
NZ (1) NZ563431A (uk)
RU (1) RU2391672C2 (uk)
WO (2) WO2007003344A2 (uk)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE381624T1 (de) 1994-05-09 2008-01-15 Oxford Biomedica Ltd Retrovirale vektoren mit verminderter rekombinationsrate
US8969089B2 (en) 2004-10-12 2015-03-03 Quest Diagnostics Investments, Inc. Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry
CA2608965C (en) * 2005-06-30 2014-08-19 Biocrates Life Sciences Ag Device for quantitative analysis of a metabolite profile
WO2007130629A1 (en) * 2006-05-05 2007-11-15 Perkinelmer Las, Inc Quantitative analysis of surface-derived samples using mass spectrometry
EP1923806A1 (en) * 2006-11-14 2008-05-21 Metanomics GmbH Fast metabolomic analysis and system therefor
US7999084B2 (en) * 2007-05-16 2011-08-16 Agilent Technologies, Inc. Devices and methods for reducing matrix effects
JP2010528302A (ja) * 2007-05-31 2010-08-19 バイオクレイツ ライフ サイエンス エージー 炎症および酸化ストレスレベル検定
US20100173342A1 (en) * 2007-05-31 2010-07-08 Weinberger Klaus Michael Biomarker and Method for Determining an Oxidative Stress Level
CA2691974C (en) * 2007-06-29 2016-08-30 Quest Diagnostics Investments Incorporated Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry
AU2008280806B2 (en) * 2007-07-26 2014-12-11 Phenomenome Discoveries Inc. Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
DE102007043614B3 (de) * 2007-09-13 2008-11-20 Biocrates Life Sciences Gmbh Halterung für ein Trägermittel zum Einsetzen in eine zylinderförmige Öffnung
WO2009043149A1 (en) * 2007-10-01 2009-04-09 Mds Analytical Technologies, A Business Unit Of Mds Inc., Doing Business Through Its Sciex Division Analysis of conjugated metabolites of alcohol consumption
US20100285593A1 (en) * 2007-11-26 2010-11-11 Waters Technologies Corporation Internal standards and methods for use in quantitatively measuring analytes in a sample
EP2297771A2 (en) * 2008-06-13 2011-03-23 Smiths Detection-Montreal Inc. Analytical instrument
CA2743211A1 (en) 2008-11-12 2010-05-20 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems of using exosomes for determining phenotypes
EP2192196A1 (en) 2008-11-27 2010-06-02 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Prediction of lipid-metabotype-related physiological susceptibilities
WO2010100816A1 (ja) 2009-03-05 2010-09-10 株式会社 日立ハイテクノロジーズ 分析装置
US9500572B2 (en) 2009-04-30 2016-11-22 Purdue Research Foundation Sample dispenser including an internal standard and methods of use thereof
CN102414778B (zh) * 2009-04-30 2016-03-16 普度研究基金会 使用潮湿的多孔材料产生离子
EP2249161B1 (en) 2009-05-05 2020-05-13 InfanDx AG Method of diagnosing asphyxia
DK2438441T3 (da) * 2009-06-02 2014-08-18 Biocrates Life Sciences Ag Nye biomarkører til vurdering af nyresygdomme
US20130203061A1 (en) 2009-11-30 2013-08-08 Michael KLASS Methods and systems for isolating, storing, and analyzing vesicles
EP2524059A4 (en) 2010-01-13 2013-11-20 Caris Life Sciences Luxembourg Holdings DETECTION OF GASTROINTESTINAL DISEASES
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
US8941059B2 (en) * 2010-10-29 2015-01-27 Atonarp, Inc. Sampling apparatus
HUE055674T2 (hu) 2010-10-29 2021-12-28 Thermo Fisher Scientific Oy Rendszerelrendezés automatizált mintaelõkészítõ és -elemzõ rendszerhez
EP2492690A1 (en) * 2011-02-22 2012-08-29 BIOCRATES Life Sciences AG Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants
EP2587264A1 (en) 2011-10-25 2013-05-01 InfanDx AG Method and use of metabolites for the diagnosis and differentiation of neonatal encephalopathy
EP3557605B1 (en) 2011-11-23 2021-07-14 Quest Diagnostics Investments Incorporated Kisspeptin-54 detection by tandem mass spectrometry
JP6198408B2 (ja) * 2012-04-02 2017-09-20 株式会社日立ハイテクノロジーズ サンプル液に含まれる揮発性物質の分析方法
US8870028B2 (en) 2012-05-25 2014-10-28 Restek Corporation Dispensing device
EP2883058B1 (en) * 2012-08-13 2018-01-03 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Biomarkers for type 2 diabetes
EP2917738A1 (de) 2012-11-12 2015-09-16 BIOCRATES Life Sciences AG Verwendung von qualitätsindikatoren zum nachweis von auftauprozessen in gefrorenen gewebeproben
WO2014110196A1 (en) * 2013-01-10 2014-07-17 Restek Corporation Dispensing device and method
CN104956462B (zh) 2013-01-31 2017-10-10 普度研究基金会 用于分析所提取样本的系统和方法
CN104956463B (zh) 2013-01-31 2018-04-06 普度研究基金会 分析原油的方法
EP4099363A1 (en) 2013-06-25 2022-12-07 Purdue Research Foundation Mass spectrometry analysis of microorganisms in samples
CN103558354B (zh) 2013-11-15 2015-07-15 南京大学 一种基于生物组学整合技术的水体毒性分析方法
JP2017101924A (ja) * 2014-03-31 2017-06-08 積水メディカル株式会社 内部標準物質試薬
CN104200087B (zh) * 2014-06-05 2018-10-02 清华大学 用于机器学习的参数寻优及特征调优的方法及系统
US9786478B2 (en) 2014-12-05 2017-10-10 Purdue Research Foundation Zero voltage mass spectrometry probes and systems
JP6948266B2 (ja) 2015-02-06 2021-10-13 パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ プローブ、システム、カートリッジ、およびその使用方法
EP3171173A1 (en) 2015-11-19 2017-05-24 Medizinische Universität Innsbruck Method of diagnosis of a thoracic aortic aneurysm
EP3397972A2 (en) 2015-12-31 2018-11-07 Universal Diagnostics, S.L. Systems and methods for automated, customizable sample preparation tool, software script, and calibration routine for detection of metabolites and lipids
DE102017112612A1 (de) * 2016-06-10 2017-12-14 Hitachi High-Tech Science Corporation Flüssigkeitschromatograph und Verfahren zum Korrigieren von Schwankungen eines Detektorausgabewerts des Flüssigkeitschromatographen
US10607723B2 (en) 2016-07-05 2020-03-31 University Of Kentucky Research Foundation Method and system for identification of metabolites using mass spectra
US11719702B2 (en) * 2016-11-07 2023-08-08 Battelle Memorial Institute Methods and systems of proteome analysis and imaging
WO2018085835A1 (en) * 2016-11-07 2018-05-11 Battelle Memorial Institute Nanoscale biochemical sample preparation and analysis
EP3351938A1 (en) * 2017-01-18 2018-07-25 BIOCRATES Life Sciences AG New biomarkers for assessing ovarian cancer
EP3376230A1 (en) 2017-03-13 2018-09-19 Biocross, S.L. Identification of signatures for neurodegeneration diseases diagnoses
WO2018174876A1 (en) * 2017-03-22 2018-09-27 Mprobe Inc. Methods and compositions for providing a preeclampsia assessment with metabolites
CN107727850B (zh) * 2017-10-10 2021-08-27 常州博闻迪医药股份有限公司 一种侧向流层析检测反应启动控制方法
WO2018210784A1 (en) * 2017-05-17 2018-11-22 Radiometer Medical Aps Porous optical fiber for the detection of an analyte in a fluid
CN107561150A (zh) * 2017-07-03 2018-01-09 宁波华仪宁创智能科技有限公司 吸毒的检测方法
CN107798981A (zh) * 2017-10-31 2018-03-13 楚雄医药高等专科学校 一种永久性教学用微囊标本片及其制作方法
CN109030673A (zh) * 2018-07-04 2018-12-18 易达精准（杭州）科技有限公司 干血片中免疫抑制剂的检测方法以及检测试剂盒
CN109298115B (zh) * 2018-10-19 2020-07-28 深圳市绘云生物科技有限公司 生物样品中多种代谢物定量检测方法及代谢芯片
WO2020099683A1 (en) 2018-11-16 2020-05-22 Biocrates Life Sciences Ag Metabolites for use in ovarian cancer detection and diagnosis
FR3091351B1 (fr) 2018-12-27 2021-05-21 Univ Rouen Centre Hospitalier Biomarqueur de la maladie de fabry
KR102035162B1 (ko) * 2019-03-12 2019-11-08 한국과학기술원 질병 표적 대사 효소에 특이적인 인체 대사 물질을 이용하여 질병에 대한 약물 후보를 예측하는 방법
CN111579665B (zh) 2020-05-20 2021-11-05 苏州帕诺米克生物医药科技有限公司 一种基于uplc/hrms的代谢组学相对定量分析方法
US20230204544A1 (en) * 2020-05-21 2023-06-29 Mayo Foundation For Medical Education And Research Calibration methods for mass spectrometry measurements
CN111704654B (zh) * 2020-06-18 2021-12-03 上海交通大学医学院附属仁济医院 肽类化合物及其制备方法与应用
US11754536B2 (en) 2021-11-01 2023-09-12 Matterworks Inc Methods and compositions for analyte quantification
JP7206365B1 (ja) 2021-12-22 2023-01-17 浜松ホトニクス株式会社 試料支持体
KR102547430B1 (ko) * 2022-11-16 2023-06-23 (주)애터미오롯 노니 함유 조성물의 정성 분석 방법
CN117538530A (zh) * 2023-11-07 2024-02-09 中国医学科学院肿瘤医院 一种检测转移性乳腺癌的生物标志组合物和试剂盒及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756362A (en) * 1993-10-12 1998-05-26 Cornell Research Foundation, Inc. Liposome-enhanced immunoaggregation assay and test device
US6358752B1 (en) 1996-09-27 2002-03-19 Cornell Research Foundation, Inc. Liposome-enhanced test device and method
GB9718129D0 (en) * 1997-08-27 1997-10-29 Isis Innovation Branched structures
US6455321B1 (en) * 1999-01-30 2002-09-24 Neo Gen Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US6258605B1 (en) * 1999-03-26 2001-07-10 Neo Gen Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry
US20020009394A1 (en) 1999-04-02 2002-01-24 Hubert Koster Automated process line
ATE343130T1 (de) * 1999-12-29 2006-11-15 Perkinelmer Life Sciences Inc Testtablett, kit und verfahren zum screening von körperflüssigkeiten von neugeborenen durch tandem-massenspektrometrie
US20020009740A1 (en) * 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
WO2002005930A1 (en) * 2000-07-18 2002-01-24 Invitrogen Corporation Device and methods for subdividing and filtering gel material and extracting molecules therefrom
US6627444B1 (en) * 2000-08-07 2003-09-30 Smiths Detection - Toronto Ltd. Method and solid phase calibration sample for calibration of analytical instructions
US20020155587A1 (en) * 2001-04-20 2002-10-24 Sequenom, Inc. System and method for testing a biological sample
EP1417629B1 (en) 2001-07-06 2008-02-20 Lipomics Technologies, Inc. Generating, viewing, interpreting, and utilizing a quantitative database of metabolites
DE60239962D1 (de) 2001-08-14 2011-06-16 Harvard College Absolute quantifizierung von proteinen und modifizierten formen davon mittels mehrstufiger massenspektrometrie
US6929944B2 (en) * 2001-08-31 2005-08-16 Beckman Coulter, Inc. Analysis using a distributed sample
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
CA2466837A1 (en) * 2001-11-13 2003-05-22 Caprion Pharmaceuticals Inc. Mass intensity profiling system and uses thereof
US6873914B2 (en) * 2001-11-21 2005-03-29 Icoria, Inc. Methods and systems for analyzing complex biological systems
GB0128498D0 (en) 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
ATE327512T1 (de) 2001-12-08 2006-06-15 Micromass Ltd Massenspektrometrie-verfahren
AUPS177202A0 (en) 2002-04-16 2002-05-23 Diakyne Pty Ltd Multi-element screening of trace elements
WO2004038602A1 (en) 2002-10-24 2004-05-06 Warner-Lambert Company, Llc Integrated spectral data processing, data mining, and modeling system for use in diverse screening and biomarker discovery applications
AU2003286726A1 (en) 2002-10-25 2004-05-13 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20040119010A1 (en) * 2002-11-01 2004-06-24 The Regents Of The University Of Colorado Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry
US20040121305A1 (en) 2002-12-18 2004-06-24 Wiegand Roger Charles Generation of efficacy, toxicity and disease signatures and methods of use thereof
US6909981B2 (en) 2003-01-27 2005-06-21 Ciphergen Biosystems, Inc. Data management system and method for processing signals from sample spots
US7964343B2 (en) * 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US20050112635A1 (en) 2003-09-22 2005-05-26 Becton, Dickinson And Company Quantification of analytes using internal standards
KR20050050714A (ko) * 2003-11-26 2005-06-01 매그나칩 반도체 유한회사 반도체소자의 트랜지스터 제조방법
US7745226B2 (en) * 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
CA2608965C (en) * 2005-06-30 2014-08-19 Biocrates Life Sciences Ag Device for quantitative analysis of a metabolite profile

Also Published As

Publication number Publication date
ES2452025T3 (es) 2014-03-31
NZ563431A (en) 2012-05-25
DK1897014T3 (en) 2014-03-10
CN101208697A (zh) 2008-06-25
WO2007003343A1 (en) 2007-01-11
KR20080025092A (ko) 2008-03-19
US20070004044A1 (en) 2007-01-04
US8265877B2 (en) 2012-09-11
AU2006265381B2 (en) 2010-06-10
EP1897014B1 (en) 2014-01-15
DK1875401T3 (da) 2014-04-07
CA2608963C (en) 2014-08-26
EP1897014A1 (en) 2008-03-12
CA2608965A1 (en) 2007-01-11
JP5155160B2 (ja) 2013-02-27
JP4829297B2 (ja) 2011-12-07
JP2008547031A (ja) 2008-12-25
IL187470A (en) 2015-02-26
CN100594501C (zh) 2010-03-17
EP1875401A2 (en) 2008-01-09
US20070003965A1 (en) 2007-01-04
BRPI0613478B1 (pt) 2019-07-09
KR100967573B1 (ko) 2010-07-05
US8116983B2 (en) 2012-02-14
WO2007003344A2 (en) 2007-01-11
RU2391672C2 (ru) 2010-06-10
NO339319B1 (no) 2016-11-28
IL187470A0 (en) 2008-03-20
RU2008102835A (ru) 2009-08-10
NO20080559L (no) 2008-01-30
CA2608963A1 (en) 2007-01-11
WO2007003344A3 (en) 2007-04-26
BRPI0613478B8 (pt) 2021-07-27
JP2008547030A (ja) 2008-12-25
AU2006265381A1 (en) 2007-01-11
EP1875401B1 (en) 2014-03-05
CA2608965C (en) 2014-08-19
BRPI0613478A2 (pt) 2012-01-17

Similar Documents

Publication Publication Date Title
IN2014DN02241A (uk)
WO2008039946A3 (en) Integrated meter for analyzing biological samples
EP1882950A4 (en) TEST CHIP FOR ANALYZING TARGET SUBSTANCE IN SUBSTANCE TO BE ANALYZED AND ANALYTICAL SYSTEM AT MICROSCOPIC SCALE
EP1819283A4 (en) SYSTEM AND METHOD FOR SAMPLING AN ANALYTE AND ANALYZING WITH HYDROGEL
EP1966731A4 (en) METHOD FOR DETERMINING THE PRESENCE OF INTERFERING SUBSTANCES IN SMALL LIQUID SAMPLES IN AN AUTOMATIC CLINICAL ANALYZER
GB0507457D0 (en) Improvements in or relating to methods and apparatus for analyzing biological samples by mass spectrometry
EP1867997A4 (en) METHOD AND DEVICE FOR ANALYZING SPECIMENS
GB2474146A (en) Methods of determining the health status of an individual
AU2013207599A1 (en) Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
EP1867978A4 (en) Method of analyte analysis and analyte analyzer
EP1960112A4 (en) ENRICHMENT UNIT FOR BIOLOGICAL COMPONENTS AND ENRICHMENT METHOD
EP1739402A4 (en) METHODS OF SEPARATING, IDENTIFYING AND ADMINISTERING SPECIMEN AND CORRESPONDING DEVICE, AND METHOD OF ANALYZING DEVICE
WO2010048431A3 (en) Device, method and apparatus for analysing skin and hair
HK1129340A1 (en) Vials and apparatus for obtaining an aliquot of a sample
GB0719821D0 (en) Method and system for sample testing
EP2772761A3 (en) Nucleic acid element for use in analysis, and analytical method, analytical reagent and analytical instrument using same
EP1672984A4 (en) METHODS FOR REDUCING THE DEPARTURE OF CONCENTRATIONS BETWEEN SPECIES OF ANALYTES IN A SAMPLE
IL172895A0 (en) Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
DE602005015559D1 (de) Pharmakodynamische tests mit durchflusszytometrie
EP1939611A4 (en) METHOD FOR DETECTING THE CONDITION OF DELIVERY OF A SAMPLE AND ANALYZER
WO2009142835A3 (en) Method and apparatus for analyzing skin and hair
EP1873522A4 (en) METHOD FOR DETERMINING A HEMOGLOBIN DERIVATIVE AND REAGENT COMPOSITION, TEST KIT, ANALYSIS DEVICE AND ANALYSIS SYSTEM FOR USE IN THE PROCESS
ZA201001253B (en) Reagent kit for sample analysis and sample analysis method
IL212082A0 (en) Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
EP1898215A4 (en) METHOD FOR ANALYZING ENDOCRINE SUBSTANCE IN A SPECIMEN